MedKoo Cat#: 600135 | Name: Ergosterol
Featured

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Ergosterol is a sterol found in fungi, and named for ergot, the common name of members of the fungal genus Claviceps from which ergosterol was first isolated. Ergosterol does not occur in plant or animal cells; reports of its isolation from plants are generally ascribed to fungal contamination of the plant material from which steroids are being isolated. Ergosterol is a component of yeast and other fungal cell membranes, serving many of the same functions that cholesterol serves in animal cells. Ergosterol is provitamin form of vitamin D2; natural ultraviolet (UV) irradiation of ergosterol, isolated or in situ, results in vitamin D2 production that can contribute to satisfying human dietary vitamin D requirements. (Source: http://en.wikipedia.org/wiki/Ergosterol).

Chemical Structure

Ergosterol
Ergosterol
CAS#57-87-4

Theoretical Analysis

MedKoo Cat#: 600135

Name: Ergosterol

CAS#: 57-87-4

Chemical Formula: C28H44O

Exact Mass: 396.3392

Molecular Weight: 396.65

Elemental Analysis: C, 84.79; H, 11.18; O, 4.03

Price and Availability

Size Price Availability Quantity
1g USD 250.00 2 Weeks
5g USD 450.00 2 Weeks
25g USD 850.00 2 Weeks
Bulk Inquiry
Buy Now
Add to Cart
Related CAS #
No Data
Synonym
Ergosterol; Ergosterin; Provitamin D; Provitamin D2.
IUPAC/Chemical Name
(3S,9S,10R,13R,14R,17R)-17-[(E,2R,5R)-5,6-dimethylhept-3-en-2-yl]-10,13-dimethyl-2,3,4,9,11,12,14,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-ol
InChi Key
DNVPQKQSNYMLRS-APGDWVJJSA-N
InChi Code
InChI=1S/C28H44O/c1-18(2)19(3)7-8-20(4)24-11-12-25-23-10-9-21-17-22(29)13-15-27(21,5)26(23)14-16-28(24,25)6/h7-10,18-20,22,24-26,29H,11-17H2,1-6H3/b8-7+/t19-,20+,22-,24+,25-,26-,27-,28+/m0/s1
SMILES Code
O[C@H]1CC[C@]2(C)[C@@]3([H])CC[C@]4(C)[C@@H]([C@@H](/C=C/[C@H](C)C(C)C)C)CC[C@@]4([H])C3=CC=C2C1
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO.
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info
Product Data
Biological target:
Ergosterol is the primary sterol found in fungi, with antioxidative, anti-proliferative, and anti-inflammatory effects.
In vitro activity:
ER (Ergosterol) significantly increased the protein expression of Nrf2 and HO-1 in chondrocytes in a dose-dependent manner (Fig. 1C and D). Nuclear protein was extracted for assays and the results showed that ER upregulated nuclear Nrf2 expression (Fig. 1E). ER treatment caused a significant increase in luciferase activity (Fig. 1F), which indicated that ER activated the HO-1 promoter transactivation activity. Reference: Exp Ther Med. 2021 Mar; 21(3): 194. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7812583/
In vivo activity:
The number of Con A-dependent aggregates was significantly higher in the carcinogenic group than that in the control group. In contrast, the number of cell aggregates was significantly lower in rats treated with ergosterol compared to the carcinogenesis group (Table 2). Reference: Biomedicines. 2020 Jul; 8(7): 180. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7400612/
Solvent mg/mL mM
Solubility
DMF 2.0 5.04
Ethanol 1.6 3.91
Ethanol:PBS (pH 7.2) (1:2) 0.3 0.76
Note: There can be variations in solubility for the same chemical from different vendors or different batches from the same vendor. The following factors can affect the solubility of the same chemical: solvent used for crystallization, residual solvent content, polymorphism, salt versus free form, degree of hydration, solvent temperature. Please use the solubility data as a reference only. Warming and sonication will facilitate dissolving. Still have questions? Please contact our Technical Support scientists.

Preparing Stock Solutions

The following data is based on the product molecular weight 396.65 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol:
1. Cai D, Yan H, Liu J, Chen S, Jiang L, Wang X, Qin J. Ergosterol limits osteoarthritis development and progression through activation of Nrf2 signaling. Exp Ther Med. 2021 Mar;21(3):194. doi: 10.3892/etm.2021.9627. Epub 2021 Jan 8. PMID: 33488803; PMCID: PMC7812583. 2. Sun X, Liu Y, Feng X, Li C, Li S, Zhao Z. The key role of macrophage depolarization in the treatment of COPD with ergosterol both in vitro and in vivo. Int Immunopharmacol. 2020 Feb;79:106086. doi: 10.1016/j.intimp.2019.106086. Epub 2019 Dec 23. PMID: 31874368. 3. Ikarashi N, Hoshino M, Ono T, Toda T, Yazawa Y, Sugiyama K. A Mechanism by which Ergosterol Inhibits the Promotion of Bladder Carcinogenesis in Rats. Biomedicines. 2020 Jun 27;8(7):180. doi: 10.3390/biomedicines8070180. PMID: 32605038; PMCID: PMC7400612. 4. Yazawa Y, Ikarashi N, Hoshino M, Kikkawa H, Sakuma F, Sugiyama K. Inhibitory effect of ergosterol on bladder carcinogenesis is due to androgen signaling inhibition by brassicasterol, a metabolite of ergosterol. J Nat Med. 2020 Sep;74(4):680-688. doi: 10.1007/s11418-020-01419-4. Epub 2020 Jun 1. PMID: 32488609.
In vitro protocol:
1. Cai D, Yan H, Liu J, Chen S, Jiang L, Wang X, Qin J. Ergosterol limits osteoarthritis development and progression through activation of Nrf2 signaling. Exp Ther Med. 2021 Mar;21(3):194. doi: 10.3892/etm.2021.9627. Epub 2021 Jan 8. PMID: 33488803; PMCID: PMC7812583. 2. Sun X, Liu Y, Feng X, Li C, Li S, Zhao Z. The key role of macrophage depolarization in the treatment of COPD with ergosterol both in vitro and in vivo. Int Immunopharmacol. 2020 Feb;79:106086. doi: 10.1016/j.intimp.2019.106086. Epub 2019 Dec 23. PMID: 31874368.
In vivo protocol:
1. Ikarashi N, Hoshino M, Ono T, Toda T, Yazawa Y, Sugiyama K. A Mechanism by which Ergosterol Inhibits the Promotion of Bladder Carcinogenesis in Rats. Biomedicines. 2020 Jun 27;8(7):180. doi: 10.3390/biomedicines8070180. PMID: 32605038; PMCID: PMC7400612. 2. Yazawa Y, Ikarashi N, Hoshino M, Kikkawa H, Sakuma F, Sugiyama K. Inhibitory effect of ergosterol on bladder carcinogenesis is due to androgen signaling inhibition by brassicasterol, a metabolite of ergosterol. J Nat Med. 2020 Sep;74(4):680-688. doi: 10.1007/s11418-020-01419-4. Epub 2020 Jun 1. PMID: 32488609.
1: Zhang YQ, Rao R. Beyond ergosterol: linking pH to antifungal mechanisms. Virulence. 2010 Nov-Dec;1(6):551-4. Epub 2010 Nov 1. Review. PubMed PMID: 21178501.